When nucleotide levels drop, a common step during initiation of aggressive cancers, ribosomes biogenesis detects it and prevent DNA replication, as this could lead to genome damage.
Ribosome biogenesis senses nucleotide levels to preserve DNA integrity Read More »
IDIBELL is seeking postdoctoral researchers interested in appling to Marie Skłodowska-Curie Actions grant (MSCA-IF). Join us!
Check our open opportunities, meet us at our MSCA-IF bootcamp Read More »
A recent donation from the Coordinating Association “Viladecans against Cancer” raises the scoreboard of the #BellvitgeInvestiga crowdfunding initiative to more than € 60,000.
We will use these funds to accelerate research projects against COVID-19.
More than € 60,000 to fight COVID-19 Read More »
The documentary narrates, with the voice of health and research personnel, the transformation of IDIBELL and the Bellvitge University Hospital to face the pandemic, from the doubling of beds for critical patients, to the launch of multiple research projects for better understanding of the new coronavirus.
The premiere of the documentary “Bellvitge, a hospital transformed by Covid-19” Read More »
Many diseases are associated with a dysregulation in blood vessel formation. Now an IDIBELL group has defined a model of pericyte maturation during vessel formation and has developed tools to study them, which could help to decipher their contribution to these diseases.
ModGraProDep is an innovative system that, through artificial intelligence and the design of probabilistic models, improves the prediction of survival indicators in breast cancer patients. This study, published in the journal Artificial Intelligence in Medicine, has been led by Ramon Clèries, professor at the Department of Clinical Sciences of the Faculty of Medicine and Health
Artificial intelligence applied to clinical oncology Read More »
The Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C]), which aims to group research on stem cells in Catalonia, now has its own space in internet.
The P-CMR[C] launches its website Read More »
The researcher Laura Valle has been awarded the CIBERONC 2020 award at the IV Annual CIBERONC Meeting held at the National School of Health of the Carlos III Health Institute in Madrid. Laura Valle, a principal investigator in the IDIBELL hereditary cancer group and CIBERONC researcher, has received the Best CIBERONC 2020 Researcher Award. The
Laura Valle has received the CIBERONC 2020 award Read More »
The new therapy, designed by the team of psychooncologist Cristian Ochoa, reduces long-term emotional distress and stress symptoms.
Positive Psychotherapy in patients who have completed cancer treatment Read More »
A group from IDIBELL and UB has demonstrated that neurons can detect a decrease in the autaptic synapse, those established with themselves, and recover the consequent fall of neurotransmission by forming and enhancing new connections.
Discovery of a new mechanism of homeostatic plasticity in autaptic neural connections Read More »
